Welcome to LookChem.com Sign In|Join Free

CAS

  • or

96761-00-1

Post Buying Request

96761-00-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96761-00-1 Usage

Uses

D-Ribal is used as a reagent in the synthesis of C-nucleoside pyrazolotriazines and their bisphosphate C-nucleotide analogs as in vivo stable P2Y1-receptor antagonists.

Check Digit Verification of cas no

The CAS Registry Mumber 96761-00-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,7,6 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 96761-00:
(7*9)+(6*6)+(5*7)+(4*6)+(3*1)+(2*0)+(1*0)=161
161 % 10 = 1
So 96761-00-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H8O3/c6-3-5-4(7)1-2-8-5/h1-2,4-7H,3H2/t4-,5+/m0/s1

96761-00-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

1.2 Other means of identification

Product number -
Other names .D-Arabinal

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:96761-00-1 SDS

96761-00-1Synthetic route

(2R,3S)-2-Triisopropylsilanyloxymethyl-2,3-dihydro-furan-3-ol
96760-93-9

(2R,3S)-2-Triisopropylsilanyloxymethyl-2,3-dihydro-furan-3-ol

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran for 0.0166667h;98%
thymidine
50-89-5

thymidine

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

Conditions
ConditionsYield
With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane for 4h; Heating;80%
Stage #1: thymidine With ammonium sulfate; 1,1,1,3,3-pentamethyldisilazane for 2h; Reflux;
Stage #2: With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 3h;
56%
Stage #1: thymidine With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane at 130℃; for 2h;
Stage #2: With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 3h;
50%
2,3-O-Isopropylidene-5-O-trityl-α,β-ribofuranosyl chloride
58166-67-9

2,3-O-Isopropylidene-5-O-trityl-α,β-ribofuranosyl chloride

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

Conditions
ConditionsYield
With ammonia; lithium In tetrahydrofuran for 2h;
2'-Deoxyguanosine
961-07-9

2'-Deoxyguanosine

17β-Estradiol-3,4-quinone
144082-88-2

17β-Estradiol-3,4-quinone

A

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

B

7-[4-hydroxyestradiol-1(α,β)-yl]guanine

7-[4-hydroxyestradiol-1(α,β)-yl]guanine

C

2-amino-9-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-7-(3,4,17-trihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-1-yl)-6,7-dihydro-1H-purin-9-ium

2-amino-9-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-7-(3,4,17-trihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-1-yl)-6,7-dihydro-1H-purin-9-ium

Conditions
ConditionsYield
With acetic acid In water; N,N-dimethyl-formamide at 22℃; pH=4.0; Product distribution;
2'-Deoxyguanosine
961-07-9

2'-Deoxyguanosine

hexestrol-3',4'-quinone
857837-21-9

hexestrol-3',4'-quinone

A

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

B

2-amino-7-{2-[1-ethyl-2-(4-hydroxy-phenyl)-butyl]-4,5-dihydroxy-phenyl}-1,7-dihydro-purin-6-one

2-amino-7-{2-[1-ethyl-2-(4-hydroxy-phenyl)-butyl]-4,5-dihydroxy-phenyl}-1,7-dihydro-purin-6-one

C

2-Amino-7-{2-[1-ethyl-2-(4-hydroxy-phenyl)-butyl]-4,5-dihydroxy-phenyl}-9-((2R,4S,5R)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-6,7-dihydro-1H-purin-9-ium

2-Amino-7-{2-[1-ethyl-2-(4-hydroxy-phenyl)-butyl]-4,5-dihydroxy-phenyl}-9-((2R,4S,5R)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-6,7-dihydro-1H-purin-9-ium

Conditions
ConditionsYield
With acetic acid In water; N,N-dimethyl-formamide at 22℃; pH=4.0; Product distribution;
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane
69304-37-6

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane

1,4-anhydro-2-deoxy-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-D-erythro-pent-1-enitol
1160370-59-1

1,4-anhydro-2-deoxy-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-D-erythro-pent-1-enitol

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide80%
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-iodo-2-methyl-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazin-4-one
476468-45-8

8-iodo-2-methyl-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazin-4-one

2-methyl-4-(N-methyl-N-phenylamino)-8-(β-D-glycero-pentofuran-3'-ulose-1'-yl)pyrazolo[1,5-a]-1,3,5-triazine
476468-46-9

2-methyl-4-(N-methyl-N-phenylamino)-8-(β-D-glycero-pentofuran-3'-ulose-1'-yl)pyrazolo[1,5-a]-1,3,5-triazine

Conditions
ConditionsYield
With tributyl-amine; triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0) In acetonitrile at 60℃; for 18h;75%
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

N-(7-iodopyrrolo[2,1-f][1,2,4]triazin-4-yl)benzamide

N-(7-iodopyrrolo[2,1-f][1,2,4]triazin-4-yl)benzamide

N-(7-((2R,5R)-5-(hydroxymethyl)-4-oxotetrahydrofuran-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)benzamide

N-(7-((2R,5R)-5-(hydroxymethyl)-4-oxotetrahydrofuran-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)benzamide

Conditions
ConditionsYield
With tributyl-amine; triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0) In N,N-dimethyl-formamide at 100℃; Heck Reaction; Inert atmosphere; regioselective reaction;60%
8-iodo-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazine
652539-01-0

8-iodo-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazine

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2′-deoxy-β-D-glyceropentofuran-3′-ulos-1′-yl)-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a][1,3,5]triazine

8-(2′-deoxy-β-D-glyceropentofuran-3′-ulos-1′-yl)-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a][1,3,5]triazine

Conditions
ConditionsYield
With triphenyl-arsane; triethylamine; bis(dibenzylideneacetone)-palladium(0) In acetonitrile at 100℃; for 16h; Solvent; Reagent/catalyst;34%
With tributyl-amine; triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0) In acetonitrile at 60℃; for 12.25h;
With triphenyl-arsane; triethylamine; bis(dibenzylideneacetone)-palladium(0) In acetonitrile at 82℃; for 16h;
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2'-deoxy-β-D-ribofuranosyl)-2-methyl-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazine
476468-47-0

8-(2'-deoxy-β-D-ribofuranosyl)-2-methyl-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 75 percent / bis(dibenzylideneacetone)palladium(0); Ph3As; (n-Bu)3N / acetonitrile / 18 h / 60 °C
2: 92 percent / sodium triacetoxyborohydride / acetonitrile / 0.33 h / 20 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2'-deoxy-β-D-xylofuranosyl)-2-methyl-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazine
476468-50-5

8-(2'-deoxy-β-D-xylofuranosyl)-2-methyl-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a]-1,3,5-triazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 75 percent / bis(dibenzylideneacetone)palladium(0); Ph3As; (n-Bu)3N / acetonitrile / 18 h / 60 °C
2: 78 percent / K-selectride / acetonitrile / 0.33 h / 20 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2'-deoxy-β-D-xylofuranosyl)-2-methyl-4-(N-methylamino)pyrazolo[1,5-a]-1,3,5-triazine 3',5'-cyclic phosphate benzyl ester
476468-52-7

8-(2'-deoxy-β-D-xylofuranosyl)-2-methyl-4-(N-methylamino)pyrazolo[1,5-a]-1,3,5-triazine 3',5'-cyclic phosphate benzyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 75 percent / bis(dibenzylideneacetone)palladium(0); Ph3As; (n-Bu)3N / acetonitrile / 18 h / 60 °C
2: 78 percent / K-selectride / acetonitrile / 0.33 h / 20 °C
3: 67 percent / ethanol / 12 h / 100 °C
4: 63 percent / t-BuOK / tetrahydrofuran / -40 - 20 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2'-deoxy-β-D-ribofuranosyl)-2-methyl-4-(N-methylamino)pyrazolo[1,5-a]-1,3,5-triazine 3',5'-bisphosphate

8-(2'-deoxy-β-D-ribofuranosyl)-2-methyl-4-(N-methylamino)pyrazolo[1,5-a]-1,3,5-triazine 3',5'-bisphosphate

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 75 percent / bis(dibenzylideneacetone)palladium(0); Ph3As; (n-Bu)3N / acetonitrile / 18 h / 60 °C
2: 92 percent / sodium triacetoxyborohydride / acetonitrile / 0.33 h / 20 °C
3: 73 percent / ethanol / 12 h / 100 °C
4: 66 percent / t-BuOK / tetrahydrofuran / -40 - 20 °C
5: 91 percent / H2 / Pd/C / methanol / 1.4 h / 20 °C / 3102.97 Torr
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2'-deoxy-β-D-ribofuranosyl)-2-methyl-4-(N-methylamino)pyrazolo[1,5-a]-1,3,5-triazine 3',5'-bis(dibenzyl phosphate)
476468-49-2

8-(2'-deoxy-β-D-ribofuranosyl)-2-methyl-4-(N-methylamino)pyrazolo[1,5-a]-1,3,5-triazine 3',5'-bis(dibenzyl phosphate)

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 75 percent / bis(dibenzylideneacetone)palladium(0); Ph3As; (n-Bu)3N / acetonitrile / 18 h / 60 °C
2: 92 percent / sodium triacetoxyborohydride / acetonitrile / 0.33 h / 20 °C
3: 73 percent / ethanol / 12 h / 100 °C
4: 66 percent / t-BuOK / tetrahydrofuran / -40 - 20 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

(2R,3S)-3-(benzyloxy)-2-((benzyloxy)methyl)-2,3-dihydrofuran
154096-13-6

(2R,3S)-3-(benzyloxy)-2-((benzyloxy)methyl)-2,3-dihydrofuran

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 1 h / Ambient temperature
2: 91 percent / NaOH, K2CO3 / dimethylsulfoxide / 2 h / Ambient temperature
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

1,3-Dimethyl-2'-deoxypseudouridine
65358-16-9

1,3-Dimethyl-2'-deoxypseudouridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) Pd(OAc)2, 2.) Na2CO3 / 1.) acetonitrile, RT, 42 h, 2.) acetonitrile, 65 deg C, 1 h
2: 21 percent / LiBH4 / tetrahydrofuran / 1.5 h / -78 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

5-(2'-deoxy-β-D-threo-pentofuranosyl)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
103003-60-7

5-(2'-deoxy-β-D-threo-pentofuranosyl)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) Pd(OAc)2, 2.) Na2CO3 / 1.) acetonitrile, RT, 42 h, 2.) acetonitrile, 65 deg C, 1 h
2: 40 percent / LiBH4 / tetrahydrofuran / 1.5 h / -78 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2’-deoxy-3’,5’-di(tert-butyldimethylsilyl)-β-D-ribofuranosyl)-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a][1,3,5]triazine

8-(2’-deoxy-3’,5’-di(tert-butyldimethylsilyl)-β-D-ribofuranosyl)-4-(N-methyl-N-phenylamino)pyrazolo[1,5-a][1,3,5]triazine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0); triethylamine / acetonitrile / 16 h / 82 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: triethylamine; bis(dibenzylideneacetone)-palladium(0); triphenyl-arsane / acetonitrile / 16 h / 100 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2′-deoxy-3′,5′-bis(tert-butyldimethylsilyl)-β-D-ribofuranosyl)-4-aminopyrazolo[1,5-a][1,3,5]triazine

8-(2′-deoxy-3′,5′-bis(tert-butyldimethylsilyl)-β-D-ribofuranosyl)-4-aminopyrazolo[1,5-a][1,3,5]triazine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0); triethylamine / acetonitrile / 16 h / 82 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4: ammonia / methanol / 19 h / 100 °C / Sealed tube
View Scheme
Multi-step reaction with 4 steps
1: triethylamine; bis(dibenzylideneacetone)-palladium(0); triphenyl-arsane / acetonitrile / 16 h / 100 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4: ammonia / methanol / 19 h / 100 °C / Sealed tube
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2’-deoxy-3’,5’-di(tert-butyldimethylsilyl)-β-D-ribofuranosyl)-4-(N-benzoylamino)-pyrazolo[1,5-a][1,3,5]triazine

8-(2’-deoxy-3’,5’-di(tert-butyldimethylsilyl)-β-D-ribofuranosyl)-4-(N-benzoylamino)-pyrazolo[1,5-a][1,3,5]triazine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0); triethylamine / acetonitrile / 16 h / 82 °C
2.1: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3.1: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4.1: ammonia / methanol / 19 h / 100 °C / Sealed tube
5.1: pyridine / 2 h / 0 - 20 °C
5.2: 0.83 h / 0 - 20 °C
View Scheme
Multi-step reaction with 5 steps
1: triethylamine; bis(dibenzylideneacetone)-palladium(0); triphenyl-arsane / acetonitrile / 16 h / 100 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4: ammonia / methanol / 19 h / 100 °C / Sealed tube
5: pyridine / 2.5 h / 0 - 20 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2′-deoxy-β-D-ribofuranosyl)-4-(N-benzoylamino)-pyrazolo[1,5-a][1,3,5]triazine

8-(2′-deoxy-β-D-ribofuranosyl)-4-(N-benzoylamino)-pyrazolo[1,5-a][1,3,5]triazine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0); triethylamine / acetonitrile / 16 h / 82 °C
2.1: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3.1: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4.1: ammonia / methanol / 19 h / 100 °C / Sealed tube
5.1: pyridine / 2 h / 0 - 20 °C
5.2: 0.83 h / 0 - 20 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 6 h / 20 °C
View Scheme
Multi-step reaction with 6 steps
1: triethylamine; bis(dibenzylideneacetone)-palladium(0); triphenyl-arsane / acetonitrile / 16 h / 100 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4: ammonia / methanol / 19 h / 100 °C / Sealed tube
5: pyridine / 2.5 h / 0 - 20 °C
6: tetrabutyl ammonium fluoride / tetrahydrofuran / 6 h / 20 °C
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2’-deoxy-5’-dimethoxytrityl-β-D-ribofuranosyl)-4-(N-benzoylamino)pyrazolo[1,5-a][1,3,5]triazine

8-(2’-deoxy-5’-dimethoxytrityl-β-D-ribofuranosyl)-4-(N-benzoylamino)pyrazolo[1,5-a][1,3,5]triazine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0); triethylamine / acetonitrile / 16 h / 82 °C
2.1: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3.1: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4.1: ammonia / methanol / 19 h / 100 °C / Sealed tube
5.1: pyridine / 2 h / 0 - 20 °C
5.2: 0.83 h / 0 - 20 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 6 h / 20 °C
7.1: pyridine / 19 h / 0 - 20 °C
View Scheme
Multi-step reaction with 7 steps
1: triethylamine; bis(dibenzylideneacetone)-palladium(0); triphenyl-arsane / acetonitrile / 16 h / 100 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4: ammonia / methanol / 19 h / 100 °C / Sealed tube
5: pyridine / 2.5 h / 0 - 20 °C
6: tetrabutyl ammonium fluoride / tetrahydrofuran / 6 h / 20 °C
7: pyridine / 19 h / 0 - 20 °C / Inert atmosphere
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-[(3′-(2-cyanoethyl)-(N,N-diisopropyl))phosphoramidite-2′-deoxy-5′-dimethoxytrityl-β-D-ribofuranosyl]-4-(N-benzoylamino)pyrazolo[1,5-a][1,3,5]triazine

8-[(3′-(2-cyanoethyl)-(N,N-diisopropyl))phosphoramidite-2′-deoxy-5′-dimethoxytrityl-β-D-ribofuranosyl]-4-(N-benzoylamino)pyrazolo[1,5-a][1,3,5]triazine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0); triethylamine / acetonitrile / 16 h / 82 °C
2.1: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3.1: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4.1: ammonia / methanol / 19 h / 100 °C / Sealed tube
5.1: pyridine / 2 h / 0 - 20 °C
5.2: 0.83 h / 0 - 20 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 6 h / 20 °C
7.1: pyridine / 19 h / 0 - 20 °C
8.1: DCI / dichloromethane / 1 h / 20 °C / Inert atmosphere
View Scheme
Multi-step reaction with 8 steps
1: triethylamine; bis(dibenzylideneacetone)-palladium(0); triphenyl-arsane / acetonitrile / 16 h / 100 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
3: 1H-imidazole / N,N-dimethyl-formamide / 60 h / 20 °C
4: ammonia / methanol / 19 h / 100 °C / Sealed tube
5: pyridine / 2.5 h / 0 - 20 °C
6: tetrabutyl ammonium fluoride / tetrahydrofuran / 6 h / 20 °C
7: pyridine / 19 h / 0 - 20 °C / Inert atmosphere
8: 4,5-dicyano-1H-imidazole / acetonitrile; dichloromethane / 1 h / 20 °C / Inert atmosphere
View Scheme
1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol
96761-00-1

1,4-anhydro-2-deoxy-D-erythro-pent-1-enitol

8-(2'-deoxy-β-D-ribofuranozyll)-4-(N-methyl-N-phenylamino)-pyrazolo[1,5a]-1,3,5-triazine

8-(2'-deoxy-β-D-ribofuranozyll)-4-(N-methyl-N-phenylamino)-pyrazolo[1,5a]-1,3,5-triazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triphenyl-arsane; bis(dibenzylideneacetone)-palladium(0); triethylamine / acetonitrile / 16 h / 82 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: triethylamine; bis(dibenzylideneacetone)-palladium(0); triphenyl-arsane / acetonitrile / 16 h / 100 °C
2: sodium tris(acetoxy)borohydride / acetonitrile / 5 h / 20 °C
View Scheme

96761-00-1Relevant articles and documents

Bilik,Kucar

, p. 311 (1970)

Synthesis and Biological Evaluation of Pyrrolo[2,1-f][1,2,4]triazine C-Nucleosides with a Ribose, 2′-Deoxyribose, and 2′,3′-Dideoxyribose Sugar Moiety

Li, Qingfeng,Lescrinier, Eveline,Groaz, Elisabetta,Persoons, Leentje,Daelemans, Dirk,Herdewijn, Piet,De Jonghe, Steven

, p. 97 - 104 (2018/01/12)

The synthesis of hitherto unknown pyrrolo[2,1-f][1,2,4]triazine C-nucleosides is described. Structural variations (chlorine, bromine, iodine, and cyano groups) were introduced at position 7 of 4-aza-7,9-dideazaadenine. In addition, pyrrolo[2,1-f][1,2,4]triazine C-nucleosides bearing a 2′-deoxy-, 2′,3′-dideoxy-, and 2′,3′-dehydrodideoxyribose moiety were also prepared. Among these analogues, the pyrrolo[2,1-f][1,2,4]triazine C-ribonucleosides with either a hydrogen atom or cyano group at position 7 of the nucleobase displayed potent cytotoxic activity in a panel of various cancer cell lines.

Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3′,4′-quinone.: Implications for mutagenic activity

Saeed, Muhammad,Zahid, Muhammad,Gunselman, Sandra J.,Rogan, Eleanor,Cavalieri, Ercole

, p. 29 - 35 (2007/10/03)

A variety of evidence has been obtained that estrogens are weak tumor initiators. A major step in the multi-stage process leading to tumor initiation involves metabolic formation of 4-catechol estrogens from estradiol (E 2) and/or estrone and further oxidation of the catechol estrogens to the corresponding catechol estrogen quinones. The electrophilic catechol quinones react with DNA mostly at the N-3 of adenine (Ade) and N-7 of guanine (Gua) by 1,4-Michael addition to form depurinating adducts. The N3Ade adducts depurinate instantaneously, whereas the N7Gua adducts depurinate with a half-life of several hours. Only the apurinic sites generated in the DNA by the rapidly depurinating N3Ade adducts appear to produce mutations by error-prone repair. Analogously to the catechol estrogen-3,4-quinones, the synthetic nonsteroidal estrogen hexestrol-3′,4′-quinone (HES-3′, 4′-Q) reacts with DNA at the N-3 of Ade and N-7 of Gua to form depurinating adducts. We report here an additional similarity between the natural estrogen E2 and the synthetic estrogen HES, namely, the slow loss of deoxyribose from the N7deoxyguanosine (N7dG) adducts formed by reaction of E2-3,4-Q or HES-3′,4′-Q with dG. The half-life of the loss of deoxyribose from the N7dG adducts to form the corresponding 4-OHE 2-1-N7Gua and 3′-OH-HES-6′-N7Gua is 6 or 8 h, respectively. The slow cleavage of this glycosyl bond in DNA seems to limit the ability of these adducts to induce mutations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 96761-00-1